Bill Sponsor
Senate Simple Resolution 18
117th Congress(2021-2022)
A resolution in support of an international investigation into the handling by the Government of the People's Republic of China of COVID-19 and the impact thereof on the people of the United States and other nations.
Introduced
Introduced
Introduced in Senate on Jan 27, 2021
Overview
Text
Introduced in Senate 
Jan 27, 2021
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Jan 27, 2021)
Jan 27, 2021
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
S. RES. 18 (Introduced-in-Senate)


117th CONGRESS
1st Session
S. RES. 18


In support of an international investigation into the handling by the Government of the People’s Republic of China of COVID–19 and the impact thereof on the people of the United States and other nations.


IN THE SENATE OF THE UNITED STATES

January 27, 2021

Mr. Hawley (for himself, Mr. Tillis, and Mr. Cramer) submitted the following resolution; which was referred to the Committee on Foreign Relations


RESOLUTION

In support of an international investigation into the handling by the Government of the People’s Republic of China of COVID–19 and the impact thereof on the people of the United States and other nations.

    Whereas the novel coronavirus, hereafter referred to as COVID–19, emerged in the People’s Republic of China and began to spread as early as November 2019;

    Whereas, by late December, dozens of citizens of the People’s Republic of China had fallen victim to COVID–19;

    Whereas, on December 30, 2019, Wuhan health authorities identified, interrogated, and reprimanded multiple doctors in response to their decisions to warn other Chinese citizens of the danger posed by this new disease;

    Whereas, on January 1, 2020, the Wuhan Public Security Bureau questioned eight Chinese doctors who had posted information on COVID–19 on WeChat;

    Whereas, on January 1, 2020, the Hubei Provincial Health Commission ordered laboratories to stop testing for COVID–19 and destroy samples of the same;

    Whereas, on January 2, 2020, the Wuhan Institute of Virology mapped the genome of COVID–19 in order to inform development of public health interventions and medical treatments for COVID–19, but the Government of the People’s Republic of China withheld genetic information on COVID–19 until January 9;

    Whereas, on January 11, 2020, the Wuhan Health Commission insisted that there were no new cases of infection by COVID–19;

    Whereas, on January 13, 2020, the first identified COVID–19 case outside of the People’s Republic of China was announced in Thailand;

    Whereas, on January 14, 2020, the World Health Organization announced that the Government of the People’s Republic of China had seen “no clear evidence of human-to-human transmission of the novel coronavirus”;

    Whereas, on January 23, 2020, the Government of the People’s Republic of China began to implement quarantine measures to stem the spread of COVID–19, at the same time as the disease had already begun to proliferate throughout the world;

    Whereas, on March 11, 2020, the World Health Organization declared COVID–19 a global pandemic, with at least 118,000 persons infected and at least 4,291 dead in 114 different countries at the time of the announcement;

    Whereas, by January 21, 2021, one year after the first COVID–19 case was confirmed in the United States, COVID–19 had infected at least 97,061,592 persons and killed at least 2,080,009 in 191 different countries;

    Whereas the Government of the People’s Republic of China argues that COVID–19 did not originate in the People’s Republic of China;

    Whereas the Ministry of Foreign Affairs of the People’s Republic of China has alleged that the United States Army may have delivered COVID–19 to the city of Wuhan and that COVID–19 may have originated in Italy or “separate outbreaks in multiple places in the world”;

    Whereas the Ministry of Foreign Affairs of the People’s Republic of China has said, “China’s endeavor to combating [sic] the epidemic has bought time for [international] preparedness.”;

    Whereas a University of Southampton study found that earlier intervention by the Government of the People’s Republic of China could have “significantly” limited the geographic spread of COVID–19;

    Whereas more than 120 nations have called for an investigation of the origins of COVID–19; and

    Whereas the Government of the People’s Republic of China continues to prevent a credible international investigation of the origins of COVID–19, including by restricting access by investigators to certain locations and information in the People’s Republic of China: Now, therefore, be it

Resolved,

That the Senate—

(1) condemns the decision by the Government of the People’s Republic of China to hide the emergence and spread of COVID–19 within its borders during the initial weeks of the pandemic;

(2) assesses that the decision by the Government of the People’s Republic of China to hide the emergence and spread of COVID–19 during that period almost certainly contributed to the rapid spread of that disease throughout the Indo-Pacific, Europe, and the rest of the world;

(3) finds that the Government of the People’s Republic of China should be held accountable for the impact of its decision to hide the emergence and spread of COVID–19 on the lives and livelihoods of the people of the United States and other nations;

(4) calls for an international investigation led by public health officials from the United States and other affected nations and free from any restrictions by the Government of the People’s Republic of China to determine how the handling by the Government of the People’s Republic of China of the COVID–19 outbreak prior to March 11, 2020, contributed to the emergence of the COVID–19 global pandemic; and

(5) calls on the international community—

(A) to quantify the harm caused by the handling of the Government of the People’s Republic of China to the health and economic well-being of the people of the United States and other nations; and

(B) to design a mechanism for delivering compensation from the Government of the People’s Republic of China to all affected nations for the harm caused by its decision to hide the emergence and spread of COVID–19 during the initial weeks of the pandemic.